Related Experiment Video
Updated: Jun 20, 2026

A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease
Published on: March 1, 2022
Impact of autonomic dysfunction on inflammatory bowel disease
Ashwin N Ananthakrishnan1, Mazen Issa, Alexandru Barboi
1Division of Gastroenterology and Hepatology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
Autonomic dysfunction (AD) in inflammatory bowel disease (IBD) patients is linked to poorer quality of life and increased healthcare use. This suggests a subgroup of IBD patients with AD may face worse health outcomes.
Area of Science:
- Gastroenterology
- Neurology
- Internal Medicine
Background:
- Functional symptoms are prevalent in inflammatory bowel disease (IBD).
- The autonomic nervous system's role in IBD pathogenesis is under investigation.
- Autonomic dysfunction (AD) may contribute to IBD-related functional symptoms and systemic issues.
Purpose of the Study:
- To investigate the impact of clinically apparent autonomic dysfunction (AD) on patients diagnosed with IBD.
- To compare health-related quality of life, disease activity, and healthcare utilization between IBD patients with and without AD.
Main Methods:
- A retrospective case-control study was conducted at a single tertiary referral IBD center.
- Cases included 43 IBD patients diagnosed with AD via standardized testing.
- Three disease-matched controls were selected for each case, with multivariate regression used for comparisons.
Main Results:
- IBD patients with AD were more likely to be female and have psychiatric comorbidity.
- Significantly longer small bowel transit times were observed in IBD patients with AD.
- AD correlated with lower quality of life (SIBDQ scores), increased gastroenterology visits, and higher rates of IBD-related hospitalizations.
Conclusions:
- Clinically manifest AD is associated with diminished quality of life and elevated healthcare utilization in IBD patients.
- IBD patients with AD may constitute a population at risk for adverse health outcomes.
- Further research into managing AD in IBD is warranted to improve patient prognosis.
Related Concept Videos
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...

